Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,381,000 | 1,194,000 | 897,000 | 1,641,000 | 1,734,000 |
| Receivables | 1,431,000 | 1,444,000 | 1,369,000 | 1,402,000 | 1,355,000 |
| Inventories | 942,000 | 878,000 | 852,000 | 853,000 | 854,000 |
| Income taxes - deferred | 825,000 | 870,000 | 864,000 | 911,000 | 995,000 |
| TOTAL | $4,962,000 | $4,796,000 | $4,574,000 | $5,452,000 | $5,287,000 |
| Non-Current Assets | |||||
| PPE Net | 1,731,000 | 1,719,000 | 1,708,000 | 1,728,000 | 1,716,000 |
| Investments And Advances | 0 | 0 | 0 | 0 | 120,000 |
| Intangibles | 19,287,000 | 19,406,000 | 0 | 19,665,000 | 0 |
| Other Non-Current Assets | 249,000 | 272,000 | 19,823,000 | 294,000 | 22,703,000 |
| TOTAL | $21,267,000 | $21,397,000 | $21,531,000 | $21,687,000 | $24,539,000 |
| Total Assets | $26,229,000 | $26,193,000 | $26,105,000 | $27,139,000 | $29,826,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 256,000 | N/A | N/A | 2,000 | N/A |
| Accounts payable and accrued liabilities | 225,000 | 213,000 | 254,000 | 239,000 | 227,000 |
| Accrued Expenses | 2,431,000 | 2,021,000 | 2,014,000 | 2,612,000 | 2,941,000 |
| Other current liabilities | 264,000 | 186,000 | 158,000 | 380,000 | 118,000 |
| TOTAL | $3,176,000 | $2,750,000 | $2,431,000 | $3,233,000 | $3,538,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,774,000 | 5,920,000 | 6,242,000 | 6,743,000 | 6,767,000 |
| Other Non-Current Liabilities | 1,849,000 | 1,944,000 | 1,911,000 | 1,727,000 | 1,507,000 |
| TOTAL | $9,756,000 | $10,029,000 | $10,398,000 | $10,732,000 | $10,598,000 |
| Total Liabilities | $12,932,000 | $12,779,000 | $12,829,000 | $13,965,000 | $14,136,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,510,430 | 1,507,498 | 1,506,407 | 1,502,237 | 1,501,524 |
| Common Shares | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 |
| Retained earnings | -2,681,000 | -2,588,000 | -2,745,000 | -2,732,000 | -337,000 |
| Other shareholders' equity | -93,000 | -22,000 | 17,000 | -53,000 | 69,000 |
| TOTAL | $13,297,000 | $13,414,000 | $13,276,000 | $13,174,000 | $15,690,000 |
| Total Liabilities And Equity | $26,229,000 | $26,193,000 | $26,105,000 | $27,139,000 | $29,826,000 |